erythromycin has been researched along with Disease Exacerbation in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, PR; Brown, RG; Holmes, E; Kindinger, LM; Lee, YS; Lehne, B; MacIntyre, DA; Marchesi, JR; Nicholson, JK; Smith, A; Terzidou, V | 1 |
| Asano, A; Nishina, T; Satou, T; Uemori, M | 1 |
| Chang, AB; Marchant, JM; Morris, PS; Petsky, HL | 1 |
| Bahar, MA; Hak, E; Kocks, JWH; Wang, Y; Wilffert, B; Zijp, TR | 1 |
| Herath, SC; Maisey, S; Normansell, R; Poole, P | 1 |
| Bruce, KD; Cuthbertson, L; Martin, ML; Rogers, GB; Serisier, DJ; Thomson, SK; van der Gast, CJ | 1 |
| Donaldson, GC; James, GD; Nazareth, I; Petersen, I; Wedzicha, JA | 1 |
| Herath, SC; Poole, P | 1 |
| Criner, GJ; Ramos, FL | 1 |
| Akagawa, KS; Hirose, T; Kobayashi, K; Nagao, T; Nakayama, T; Ōmura, S; Oshima, M; Sugamata, R; Sugawara, A; Sunazuka, T; Suzuki, K; Yamamoto, K | 1 |
| Allen, LN | 1 |
| Yamaya, M | 1 |
| Martin, ML; Serisier, DJ | 1 |
| Alujević, A; Andjelinović, S; Janković, S; Marasović, D; Mise, K; Tocilj, J | 1 |
| Chantarotorn, S; Palwatwichai, A; Tantamacharik, D; Vattanathum, A | 1 |
| Kitada, H; Konishi, Y; Murakawa, K; Sakitani, H; Sasaki, Y; Shiraiwa, K; Takahama, M; Tsujiuchi, T; Tsutsumi, M; Yoshimoto, M | 1 |
| Lee, B | 1 |
6 review(s) available for erythromycin and Disease Exacerbation
| Article | Year |
|---|---|
Antibiotics for prolonged wet cough in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Cough; Disease Progression; Erythromycin; Humans; Infant; Intention to Treat Analysis; Randomized Controlled Trials as Topic; Sputum | 2018 |
Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Bacterial Infections; Disease Progression; Erythromycin; Hospitalization; Humans; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic | 2018 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Disease Progression; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic | 2013 |
Use of long-term macrolide therapy in chronic obstructive pulmonary disease.
Topics: Anti-Bacterial Agents; Azithromycin; Cost-Benefit Analysis; Disease Progression; Drug Administration Schedule; Drug Resistance, Bacterial; Erythromycin; Humans; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sputum; Time Factors; Treatment Outcome | 2014 |
[Effects of mucolytic agents and macrolides in the treatment of COPD].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antiviral Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Erythromycin; Expectorants; Goblet Cells; Humans; Hyperplasia; Macrolides; Mucins; Mucociliary Clearance; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Treatment Outcome | 2016 |
1 trial(s) available for erythromycin and Disease Exacerbation
| Article | Year |
|---|---|
Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bronchi; Bronchiectasis; Bronchoalveolar Lavage Fluid; Colony Count, Microbial; Cross-Sectional Studies; Cystic Fibrosis; Disease Progression; DNA, Bacterial; Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Forced Expiratory Volume; Humans; Male; Metagenome; Middle Aged | 2013 |
10 other study(ies) available for erythromycin and Disease Exacerbation
| Article | Year |
|---|---|
Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin.
Topics: Adult; Antibiotic Prophylaxis; Cohort Studies; Disease Progression; Dysbiosis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Microbiota; Neonatal Sepsis; Pregnancy; Premature Birth; Prenatal Care; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 16S; Vagina | 2018 |
[A case of relapsed neurosyphilis with progressive left hemiparesis].
Topics: Antibodies, Bacterial; Biomarkers; Diffusion Magnetic Resonance Imaging; Disease Progression; Drug Substitution; Erythromycin; Humans; Male; Middle Aged; Neurosyphilis; Paresis; Penicillin G; Recurrence; Treatment Outcome; Treponema pallidum | 2018 |
Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cohort Studies; Disease Progression; Doxycycline; Erythromycin; Female; Humans; Longitudinal Studies; Male; Middle Aged; Oxytetracycline; Penicillins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Sex Factors; United Kingdom | 2013 |
Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Clarithromycin; Cytokines; Disease Models, Animal; Disease Progression; Drug Design; Epithelial Cells; Erythromycin; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Josamycin; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Spiramycin; Survival Rate | 2014 |
Mild meningococcaemia, pyrexia protocols and a problematic public health response.
Topics: Bacteremia; Disease Progression; Emergency Service, Hospital; Erythromycin; Fever; Fluid Therapy; Humans; Meningococcal Infections; Monitoring, Physiologic; Needs Assessment; Neisseria meningitidis; Public Health; Recurrence; Risk Assessment; Severity of Illness Index; Tonsillitis; Treatment Outcome; Young Adult | 2014 |
Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchiectasis; Disease Progression; Dose-Response Relationship, Drug; Erythromycin; Female; Humans; Male; Middle Aged | 2011 |
A case of syphilitic interstitial pulmonary fibrosis.
Topics: Aged; Anti-Bacterial Agents; Disease Progression; Erythromycin; Fatal Outcome; Female; Humans; Pulmonary Fibrosis; Syphilis Serodiagnosis; Syphilis, Latent; Treponema pallidum | 1998 |
Diffuse panbronchiolitis, the first case reports in Thailand.
Topics: Aged; Anti-Bacterial Agents; Bronchiolitis; Chronic Disease; Disease Progression; Erythromycin; Female; Humans; Male; Middle Aged; Prognosis; Thailand; Treatment Outcome | 1999 |
Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats.
Topics: Adenocarcinoma; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Carcinogens; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cocarcinogenesis; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Drugs, Chinese Herbal; Erythromycin; Gene Expression Regulation; Inflammation; Lung Neoplasms; Macrophages; Male; Neutrophils; Nitrosamines; Penicillins; Piroxicam; Plant Extracts; Pneumonia, Bacterial; Rats; Rats, Sprague-Dawley; Scutellaria baicalensis; Specific Pathogen-Free Organisms | 2000 |
Progressive respiratory distress in an infant treated for presumed pertussis.
Topics: Bordetella pertussis; Cough; Diagnosis, Differential; Disease Progression; Erythromycin; Humans; Infant; Lymphocytosis; Male; Microbial Sensitivity Tests; Nasopharynx; Respiratory Insufficiency; Respiratory Tract Infections; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough | 2000 |